Free trivalent actinide and lanthanide metal ions (An(III)/Ln(III) ions)

Free trivalent actinide and lanthanide metal ions represent a critical class of exogenous toxicological targets primarily encountered through industrial exposure or radiological emergencies. These f-block elements, including isotopes of americium (Am3+), curium (Cm3+), and various lanthanides (Ln3+), pose severe health risks due to their chemical toxicity and, in the case of actinides, their high-energy alpha-particle emissions [Taylor, 1989]. Once in the systemic circulation, these ions effectively mimic essential biological cations like calcium and iron, leading to rapid sequestration in mineralized bone and the liver [Pałasz & Czekaj, 2000]. Long-term deposition in these tissues can result in chronic radiation damage, significantly increasing the risk of osteosarcoma and hepatic failure [National Research Council, 2006]. Therapeutic intervention focuses on decorporation using chelating agents such as Diethylenetriaminepentaacetic acid (DTPA), which form stable, non-toxic complexes that facilitate the excretion of the metals through the kidneys [FDA, 2004]. Current research is directed toward developing novel ligands, such as hydroxypyridinone (HOPO) derivatives, which offer improved affinity and potential oral bioavailability compared to existing treatments [Abergel et al., 2010].

Other names

Trivalent f-block elementsTrivalent lanthanidesTrivalent actinidesLn3+ ionsAn3+ ionsRadionuclides

Chelation therapy: The drugs act as high-affinity ligands that sequester free metal ions into stable, water-soluble complexes, preventing tissue deposition and facilitating rapid renal or biliary excretion.